| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.043 | 0.7 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.7 |